Neogenomics Inc’s filing revealed that its General Counsel Olivo Alicia C unloaded Company’s shares for reported $79475.0 on Nov 15 ’24. In the deal valued at $15.36 per share,5,175 shares were sold. As a result of this transaction, Olivo Alicia C now holds 37,129 shares worth roughly $0.56 million.
Then, ALICIA OLIVO bought 5,175 shares, generating $81,713 in total proceeds.
Before that, Olivo Alicia C sold 1,040 shares. Neogenomics Inc shares valued at $16,695 were divested by the General Counsel at a price of $16.05 per share. As a result of the transaction, Olivo Alicia C now holds 43,813 shares, worth roughly $0.67 million.
The Benchmark Company downgraded its Neogenomics Inc [NEO] rating to a Hold from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in early December with a ‘”a Buy”‘ rating. BTIG Research maintained its rating on December 29, 2023. It rated NEO as “a Buy”.
Price Performance Review of NEO
On Tuesday, Neogenomics Inc [NASDAQ:NEO] saw its stock jump 0.93% to $15.18. Over the last five days, the stock has gained 7.05%. Neogenomics Inc shares have fallen nearly -7.89% since the year began. Nevertheless, the stocks have fallen -4.53% over the past one year. While a 52-week high of $19.11 was reached on 01/08/25, a 52-week low of $12.12 was recorded on 01/13/25. SMA at 50 days reached $16.40, while 200 days put it at $15.15.
Levels Of Support And Resistance For NEO Stock
The 24-hour chart illustrates a support level at 14.92, which if violated will result in even more drops to 14.67. On the upside, there is a resistance level at 15.38. A further resistance level may holdings at 15.58. The Relative Strength Index (RSI) on the 14-day chart is 47.16, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.06, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 56.29%. Stochastics %K at 41.51% indicates the stock is a holding.
How much short interest is there in Neogenomics Inc?
A steep rise in short interest was recorded in Neogenomics Inc stocks on 2025-01-15, dropping by -0.37 million shares to a total of 3.55 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 3.92 million shares. There was a decline of -10.39%, which implies that there is a negative sentiment for the stock.
